Zura Bio market cap ZURA
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $322M
- Highest close in our data
- $597M
- Sep 2026
Zura Bio is worth $322M at the close on Oct 23, 2026, at $3.36 a share.
That is up 34% over the last year.
Its highest close in our data was $597M in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $322M | $312.8M | $597M | +6% |
| 2025 | $302.4M | $62.5M | $302.4M | +85% |
| 2024 | $163.2M | $89.4M | $385.3M | −20% |
| 2023 | $203.6M | $26.5M | $507.5M | n/a |
Against its peers
Companies in Biotechnology nearest Zura Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| ZURAZura Bio | $322M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Zura Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.